Innovative Eyewear (NASDAQ:LUCY – Get Free Report) and Anteris Technologies Global (NASDAQ:AVR – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.
Valuation & Earnings
This table compares Innovative Eyewear and Anteris Technologies Global”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Innovative Eyewear | $2.66 million | 2.84 | -$7.59 million | ($1.29) | -0.67 |
| Anteris Technologies Global | $1.91 million | 299.52 | -$94.14 million | ($1.95) | -3.01 |
Innovative Eyewear has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
1.0% of Innovative Eyewear shares are owned by institutional investors. 1.8% of Innovative Eyewear shares are owned by company insiders. Comparatively, 4.5% of Anteris Technologies Global shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Analyst Ratings
This is a breakdown of current ratings and price targets for Innovative Eyewear and Anteris Technologies Global, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Innovative Eyewear | 1 | 1 | 0 | 0 | 1.50 |
| Anteris Technologies Global | 1 | 1 | 3 | 0 | 2.40 |
Anteris Technologies Global has a consensus target price of $14.00, indicating a potential upside of 138.50%. Given Anteris Technologies Global’s stronger consensus rating and higher possible upside, analysts clearly believe Anteris Technologies Global is more favorable than Innovative Eyewear.
Profitability
This table compares Innovative Eyewear and Anteris Technologies Global’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Innovative Eyewear | -225.26% | -88.90% | -80.34% |
| Anteris Technologies Global | -4,619.27% | -77.69% | -67.99% |
Volatility & Risk
Innovative Eyewear has a beta of 2.74, meaning that its stock price is 174% more volatile than the S&P 500. Comparatively, Anteris Technologies Global has a beta of 1.87, meaning that its stock price is 87% more volatile than the S&P 500.
About Innovative Eyewear
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Receive News & Ratings for Innovative Eyewear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovative Eyewear and related companies with MarketBeat.com's FREE daily email newsletter.
